Search Tag: prostate cancer

IMAGING Management

Pai-may-be-more-effective-for-viewing-prostate-cancer

2016 18 Jul

Photoacoustic imaging (PAI) may be an effective tool for more accurately viewing and monitoring prostate cancer, according to findings by a team of researchers led by scientists from Roswell Park Cancer Institute in Buffalo, New York.   The challenge for clinicians has been to monitor and distinguish early-stage tumors from advanced cases,...Read more

Health Management

Prostate-cancer-diagnosis-and-management

2016 01 Jul

Clinical Trial to Test If MRI Can Replace Current Standard of Care A team of scientists in Canada has secured funding for a ‏three-year Phase III clinical trial focused on improving ‏the way we biopsy for prostate cancer and whether ‏magnetic resonance imaging (MRI) can replace the current ‏standard of care to diagnose prostate cancer.   The...Read more

IMAGING Management

Uab-researchers-to-probe-prostate-with-3d-us-biobot

2016 15 Jun

Researchers in the United States are conducting tests using an image-guided biopsy robot (biobot) system to diagnose and support treatment of prostate cancer, just as about a thousand patients in Asia and Europe have already benefited from the tool that offers precise localisation. The University of Alabama at Birmingham is one of two beta...Read more

IMAGING Management

Rsi-with-mri-distinguishes-prostate-cancer-tumour-grade

2016 02 Jun

Physicians have long used MRI to detect cancer, but results of a study in California describe the potential use of RSI as an imaging biomarker that enhances the ability to differentiate aggressive prostate cancer from low-grade or benign tumours and guide treatment and biopsy. "Noninvasive imaging is used to detect disease, but RSI-MRI takes...Read more

Executive Health Management

New-model-for-surveillance-of-prostate-cancer-prevents-overtreatment

2016 29 Apr

Urologists at University of California San Diego School of Medicine and Genesis Healthcare Partners have tested a new model of care for patients with low-risk prostate cancer. The evidence-based approach uses best practices to appropriately select and follow patients to avoid disease overtreatment. Results of the three-year study are now published...Read more

IMAGING Management

Bigger-dose-will-not-improve-prostate-cancer-survival

2016 31 Mar

A bigger radiation dose will not improve the long-term chances of patients with non-metastatic prostate cancer, a new study in the U.S. by Thomas Jefferson University has found. Despite advances in technology that has allowed doctors to administer higher radiation doses to prostate cancer patients with fewer side effects, the new study, published...Read more

IMAGING Management

Screening-in-older-people-when-not-to

2016 22 Jan

Researchers in the U.S. have found that nearly 16 percent of individuals 65 years or older may have received non-recommended screenings for breast and prostate cancers because they had limited life expectancies of less than 10 years. The finding, reported in JAMA Oncology , could help inform measures to curb unnecessary and potentially harmful cancer...Read more

IMAGING Management

Does-cancer-screening-really-save-lives

2016 11 Jan

Amidst growing appreciation of the harms of cancer screening, advocates still claim that it “saves lives". However, this assertion is based on reductions in disease specific mortality rather than overall mortality, according to a BMJ article published by Vinay Prasad, MD, MPH, Assistant Professor at Oregon Health and Science University, and colleagues....Read more

IMAGING Management

Multimodality-imaging-in-cancer-management

2015 17 Dec

Using PET/CT with whole-body MRI (WBMRI) is effective in detecting extraskeletal disease, according to Stanford University researchers who suggest that this technique may change the management of high-risk breast and prostate cancer patients. The researchers also found that the combined administration of F-18 sodium fluoride (NaF) and F-18 fluorodeoxyglucose...Read more

IMAGING Management

Pet-imaging-detects-fast-growing-prostate-cancer

2015 25 Aug

A Johns Hopkins-led study shows that PET imaging with a specific biomarker could detect fast-growing primary prostate cancer and distinguish it from benign prostate lesions. The finding, reported in The Journal of Nuclear Medicine , is important for patients with suspected prostate cancer that has not been confirmed by standard biopsy. The study...Read more

IMAGING Management

Mri-screening-for-prostate-cancer

2015 17 May

Researchers at University of Gothenburg (Sweden) say a new method that combines a traditional PSA test with an MRI can detect a significantly greater number of prostate cancer cases and improve diagnostic accuracy. They conducted the study as part of the largest international research project on prostate cancer. Based on 384 Swedish subjects, the study...Read more

IMAGING Management

Mri-prostate-specific-antigen-screening-improves-cancer-detection

2015 25 Mar

Early results from the Göteborg randomised screening trial show that the use of MRI alongside conventional prostate cancer screening may offer improved cancer detection and may help in avoiding unnecessary biopsies. The Göteborg Trial is the Swedish arm of the European Randomised Study of Screening for Prostate Cancer, the largest randomised prostate...Read more

IMAGING Management

Regional-behaviours-may-contribute-to-inappropriate-imaging

2015 12 Mar

A study published online in JAMA Oncology has found an association between high rates of inappropriate imaging for breast cancer and prostate cancer, diseases for which specialist physicians do not overlap. The revelation suggests that regional infrastructure and culture may contribute to the sometimes inappropriate utilisation of healthcare resources,...Read more

IMAGING Management

Rsi-mri-detects-spread-of-cancer-beyond-prostate

2015 11 Mar

A pilot clinical study involving nine prostate cancer patients has compared standard MRI with a new clinical imaging technique that has the ability to identify less severe forms of the disease, potentially saving patients unnecessary treatment. The new technique generates more precise images so that surgeons are better able to determine the extent...Read more

IMAGING Management

Prostate-cancer-diagnosis-targeted-mri-ultrasound-beats-standard-biopsy

2015 30 Jan

A large-scale study shows that targeted biopsy using new fusion technology that combines magnetic resonance imaging (MRI) with ultrasound is more effective than standard biopsy in detecting high-risk prostate cancer. Researchers found that 30 percent more high-risk prostate cancers were diagnosed with targeted fusion-guided biopsy than with standard...Read more

IMAGING Management

New-mri-technique-improves-prostate-cancer-detection

2015 08 Jan

A new imaging technique that measurably improves upon current prostate imaging could have significant implications for how patients with prostate cancer are ultimately treated. The new method called restriction spectrum imaging-MRI (RSI-MRI) was developed by researchers from the University of California, San Diego School of Medicine, and University...Read more

Executive Health Management

Aggressive-prostate-cancer-treatment-defies-guidelines

2014 10 Dec

The first study of its kind by UCLA researchers has found that despite the fact that more than half of prostate cancer patients 66 years of age and older have life expectancies of less than ten years, half of them are over-treated for prostate cancer with surgery, radiation or brachytherapy. National guidelines recommend that men with life expectancy of...Read more

IT Management

How-3d-printing-is-reshaping-medical-practice

2014 08 Dec

Three-dimensional (3D) printing is increasingly being used in medical practice, but its implications for healthcare may be complex, according to a commentary published in JAMA . Although questions remain about how best to use the technology, experts say that 3D printing is already changing patient care. In fact, 3D printing has been used in dentistry...Read more

Pharmacy Management

Prescriptions-for-bisphosphonates-remain-low

2014 08 Dec

According to a study published in JAMA, prescriptions for bisphosphonates, a class of drugs used to strengthen bone for men on androgen deprivation therapy (ADT) and for those at high risk of subsequent fractures, remain low despite guidelines recommending their use.   ADT is widely used in men suffering from prostate cancer. Common adverse effects...Read more

Lab Management

Biomarker-predicts-aggressive-prostate-cancer

2014 04 Oct

A new study has identified a biomarker living beside the KLK3 gene that can predict which GS7 prostate cancer patients will have a more aggressive form of cancer, according to a Science Newsline report. The KLK3 gene is located on chromosome 19 and is responsible for encoding the prostate-specific antigen (PSA). Results of the study published in...Read more

IMAGING Management

Fda-panel-disapproves-of-hifu-for-prostate-cancer

2014 05 Aug

The company marketing Ablatherm Integrated Imaging High Intensity Focused Ultrasound (HIFU), used to treat low-risk prostate cancer, has failed to get the nod of U.S. Food and Drug Administration (FDA) on its premarket approval application. HIFU, which has been used in other countries for about 15 years, is marketed in Europe by EDAP TMS, a French...Read more

IMAGING Management

Mri-ultrasound-study-for-targeted-prostate-biopsy-receives-cem-award

2013 14 Nov

  During the recently held EAU 13th Central European Meeting (CEM) in Prague, Czech Republic, the study entitled ‘Using Magnetic Resonance Imaging-Ultrasound (MRIUS)- guided prostate biopsy has high sensitivity to detect prostate abnormalities compared with transrectal ultrasonography (TRUS biopsy) of MRI positive findings’ won the first prize from...Read more